The Chalfont Seizure Severity Scale.

Cramer JA, Smith DB, Mattson RH, et al. A method of quantification for the evaluation of antiepileptic drug therapy. Neurology (NY) 1983;33 (Suppl 1):26-37.

Gruber CM, Mosier JM, Grant P. Objective comparison of primidone and phenobarbital in epileptics. J Pharmacol Exp Ther 1957;120:184-7.

Cereghino JJ, Brock JT, Van Meter JC et al. Evaluation of albutoin as an antiepileptic drug. Clin Pharmacol Ther 1974;15:406-16.

Callaghan N, O'Callaghan M, Duggan B, Feely M. Carbamazepine as a single drug in the treatment of epilepsy. J Neurol Neurosurg Psychiatry 1978;41:907-12.

Fallowfield L. The quality of life. London: Souvenir Press, 1990:234.

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.

British Standards Institution. Precision of test methods I: Guide for the determination and reproducibility for a standard test method (BS 5497, part 1). London: BSI, 1979.

Baker GA, Smith DF, Chadwick DW, Morrow J. A seizure severity scale as a potential outcome measure in the assessment of efficacy of treatment of intractable epilepsy. Acta Neurol Scand 1990;82 (Suppl 133):31.

Duncan JS. Medical factors affecting quality of life in patients with epilepsy. In: Chadwick DW, ed. Quality of life and quality of care in epilepsy. Roy Soc Medi Round Table Series 1990;23:80-91.

Commission on classification and terminology of the International League against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.